Business
Mission BioCapital Announces Opening of $4 Million 2026 Platinum Program Contest and 2025 Platinum Ticket Investments
Mission BioCapital (MBC), in partnership with sponsors AbbVie, Ono Venture Investment (OVI), Toronto Innovation Acceleration Partners (TIAP), Connecticut Innovations, Alloy Therapeutics, HitGen, CCRM, Goodwin, Norton Rose Fulbright, and van den Boom & Associates announced today that applications are open internationally for the 2026 Platinum Program. MBC's Platinum Program aims to advance high-potential life sciences start-up companies by providing pre-seed funding, global laboratory space, expe
About this update from Abbvie Inc.
[{"type":"text","content":"— Up to eight winners to receive up to $500,000 each in pre-seed funding, incubator space, equity for discovery services, and expert mentorship—","length":144,"tagName":"p","attribs":{}},{"type":"text","content":"— New sponsors AbbVie, TIAP, Connecticut Innovations, CCRM, and Norton Rose Fulbright join existing partners Mission BioCapital, Ono Venture Investment, Alloy Therapeutics, HitGen, Goodwin, and van den Boom & Associates to support high-potential biotechnology innovation around the globe —","length":293,"tagName":"p","attribs":{}},{"type":"text","content":"CAMBRIDGE, Mass., April 2, 2026 /PRNewswire/ -- Mission BioCapital (MBC), in partnership with sponsors AbbVie, Ono Venture Investment (OVI), Toronto Innovation Acceleration Partners (TIAP), Connecticut Innovations, Alloy Therapeutics, HitGen, CCRM, Goodwin, Norton Rose Fulbright, and van den Boom & Associates announced today that applications are open internationally for the 2026 Platinum Program. MBC's Platinum Program aims to advance high-potential life sciences start-up companies by providing pre-seed funding, global laboratory space, expert mentorship, and discovery services to accelerate their launch and initial development. Early-stage biotechnology innovators from around the globe are invited to apply.","length":731,"tagName":"p"},{"type":"text","content":""Since 2022, Mission BioCapital's Platinum Program has helped launch 24 exceptional early-stage founders, deploying a total of $11.5 million in pre-seed funding and hands-on support to turn breakthrough ideas into medical breakthroughs," said Jennifer Griffin, Ph.D., Partner, Mission BioCapital. "We're thrilled to celebrate our alumni's ongoing achievements and excited to extend Platinum Program access to the next wave of biotech visionaries from around the world."","length":501,"tagName":"p"},{"type":"text","content":"The 2026 Platinum Program will award each of up to eight winning start-ups:","length":75,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"A guaranteed lab bench in one of MBC's 31 affiliated incubators located in 22 cities in the U.S., Canada, Europe, and Japan","length":127,"tagName":"p"}]},{"val":[{"type":"text","content":"Up to $500,000 of pre-seed capital from MBC, AbbVie, OVI, TIAP, and Connecticut Innovations","le...